Evidence map›Paper›PMID 40080415›Full record

ArticleeLife2025

HIV-1 Vif disrupts phosphatase feedback regulation at the kinetochore, leading to a pronounced pseudo-metaphase arrest.

Dhaval Ghone, Edward L Evans, Madison Bandini, Kaelyn G Stephenson, Nathan M Sherer, Aussie Suzuki

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. HIV-1 Vif and Vpr cooperatively modulate the cell cycle to maximize per-cell virion production.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Dhaval Ghone *McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, United States.ORCID https://orcid.org/0009-0003-8079-7063
Edward L Evans *McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, United States.
Madison BandiniMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, United States.
Kaelyn G StephensonMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, United States.
Nathan M ShererMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, United States.ORCID https://orcid.org/0000-0001-9974-236X
Aussie SuzukiMcArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin-Madison, Madison, United States.ORCID https://orcid.org/0000-0001-7390-5116

Funding

Visualizing EBV and HCMV DNA Dynamics During InfectionP01CA022443 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Paul F. Lambert · 1985 to 2026
$53.1M
Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
The Cell Biology of HIV-1 Genome TraffickingR01AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Nathan M Sherer · 2014 to 2026
$4.4M
Chromosome dynamics and organizations necessary for faithful chromosome segregationR35GM147525 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Aussie Suzuki · 2022 to 2026
$2.5M
National Institute of Allergy and Infectious Diseases R01AI110221National Institute of Allergy and Infectious Diseases U54AI170660NCI NIH HHS P01 CA022443NCI NIH HHS P01CA022443NCI NIH HHS T32 CA009135NIAID NIH HHS R01 AI110221NIAID NIH HHS U54 AI170660NIGMS NIH HHS R35 GM147525NIGMS NIH HHS R35GM147525University of Wisconsin Office of the Vice Chancellor for Research Research Forward
6 · The paper itself

Abstract

Virion Infectivity Factor (Vif) of the Human Immunodeficiency Virus type 1 (HIV-1) targets and degrades cellular APOBEC3 proteins, key regulators of intrinsic and innate antiretroviral immune responses, thereby facilitating HIV-1 infection. While Vif's role in degrading APOBEC3G is well-studied, Vif is also known to cause cell cycle arrest, but the detailed nature of Vif's effects on the cell cycle has yet to be delineated. In this study, we employed high-temporal resolution single-cell live imaging and super-resolution microscopy to monitor individual cells during Vif-induced cell cycle arrest. Our findings reveal that Vif does not affect the G2/M boundary as previously thought. Instead, Vif triggers a unique and robust pseudo-metaphase arrest, distinct from the mild prometaphase arrest induced by Vpr. During this arrest, chromosomes align properly and form the metaphase plate, but later lose alignment, resulting in polar chromosomes. Notably, Vif, unlike Vpr, significantly reduces the levels of both Protein Phosphatase 1 (PP1) and 2 A (PP2A) at kinetochores, which regulate chromosome-microtubule interactions. These results unveil a novel role for Vif in kinetochore regulation that governs the spatial organization of chromosomes during mitosis.

Indexed as

Cell Cycle CheckpointsFeedback, PhysiologicalHIV-1KinetochoresMetaphaseProtein Phosphatase 2vif Gene Products, Human Immunodeficiency VirusHeLa CellsHumansProtein Phosphatase 2vif Gene Products, Human Immunodeficiency Virusvif protein, Human immunodeficiency virus 1cell cycleHIVinfectious diseasemicrobiologymitosisprotein phosphataseVifvirusesVpr

Identifiers

PMID40080415
PMCPMC11906157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.